When warfarin reversal must be
accomplished rapidly, such as in cases of active bleeding or in
preparation for an invasive procedure, multiple options exist, chief
among them being fresh frozen plasma (FFP) and four factor
prothrombin complex concentrate (4-PCC). Between those two options,
the ACCP guidelines suggest (soft recommendation) 4-PCC over
FFP. This was based on low level data (very small studies) showing
more rapid INR reversal using the former. This study,
which came out after publication of the ACCP guidelines, added
further weight in favor of 4-PCC in patients deemed appropriate for
rapid warfarin reversal in the emergency setting. Though considered
low level in that it was a retrospective study, it was larger (around
150 patients in both groups) than prior studies. Despite mounting
evidence in favor of 4-PCC some experts (e.g. the authors of this review) remain skeptical as
to whether 4-PCC is superior, awaiting information from randomized
controlled trials. One such trial has been completed
but, as far as I can tell, the results have not been announced. That
study, however, enrolled only patients needing urgent warfarin
reversal in preparation for an invasive procedure. Though it will
shed further light it is unlikely to settle the controversy.
An appeal of
4-PCC is it's rapid acquisition and ease of administration. One of
the concerns has been a possible risk of thrombotic complications
compared to FFP. That concern was not realized in the retrospective
study referenced above.
No comments:
Post a Comment